Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cassava Sciences Inc
(NQ:
SAVA
)
27.42
-2.01 (-6.83%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,511,098
Open
29.57
Bid (Size)
28.00 (12)
Ask (Size)
28.16 (1)
Prev. Close
29.43
Today's Range
27.25 - 30.04
52wk Range
8.790 - 42.20
Shares Outstanding
41,969,994
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Cassava Sciences Stock Dived by Almost 11% Today
September 27, 2024
Without admitting wrongdoing, the company put a regulatory controversy to rest, but this was expensive.
Via
The Motley Fool
Cassava Sciences Unusual Options Activity
September 27, 2024
Via
Benzinga
Performance
YTD
+22.30%
+22.30%
1 Month
-2.00%
-2.00%
3 Month
+132.57%
+132.57%
6 Month
+39.12%
+39.12%
1 Year
+63.21%
+63.21%
More News
Read More
Cassava Sciences, enVVeno Medical And Other Big Stocks Moving Lower In Friday's Pre-Market Session
September 27, 2024
Via
Benzinga
SEC Charges Cassava Sciences Over Manipulated Alzheimer's Trial Data, Company And Former Execs Agree To Pay Penalty
September 27, 2024
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 27, 2024
Via
Benzinga
Here's How Much $100 Invested In Cassava Sciences 5 Years Ago Would Be Worth Today
August 07, 2024
Via
Benzinga
Market Whales and Their Recent Bets on SAVA Options
August 06, 2024
Via
Benzinga
What's Going On With Cassava Sciences Today?
August 05, 2024
Via
Benzinga
Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket
September 27, 2024
Via
Benzinga
Cassava Sciences Resolves SEC Investigation
September 26, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences Stock Rises On Interim Safety Review Of Simufilam Phase 3 Trials
September 24, 2024
Via
Benzinga
Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
September 24, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
(SAVA) - Analyzing Cassava Sciences's Short Interest
August 02, 2024
Via
Benzinga
Cassava Sciences Names Rick Barry as Chief Executive Officer
September 09, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference
September 03, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
9 Health Care Stocks Whale Activity In Today's Session
August 13, 2024
Via
Benzinga
Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
August 10, 2024
Via
MarketBeat
SAVA Stock Earnings: Cassava Sciences Beats EPS for Q2 2024
August 08, 2024
Via
InvestorPlace
Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates
August 08, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences News: Why Is SAVA Stock Trending Today?
August 06, 2024
Via
InvestorPlace
Cassava Sciences Mourns the Death of Board Member Sanford “Sandy” Robertson
August 05, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences Shares Are Trading Higher Today: What You Need To Know
August 02, 2024
Via
Benzinga
Get Your Money Out of These 3 Healthcare Stocks ASAP
August 02, 2024
Via
InvestorPlace
8 Best-Performing Small Caps In July: Find Out Which Stock Jumped 803%
August 01, 2024
Via
Benzinga
Cassava Sciences to Hold Conference Call to Discuss Recent Developments and Provide a Company Update on Thursday, August 8, 2024 at 8:30 am ET
August 01, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.